My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

West Pharmaceutical Services, Inc. Common Stock (NY:WST)

261.36 -5.30 (-1.99%)

Official Closing Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about West Pharmaceutical Services, Inc. Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

West Pharmaceutical Servs's Ex-Dividend Date Is Monday, Here's What You Need To Know ↗

January 13, 2022

Monday marks the last chance for investors to receive the next dividend payout from West Pharmaceutical Servs. What's Happening

Via Benzinga

Microsoft, Google Lead 5 Long-Term Leaders Near Buy Points ↗

December 24, 2021

Microsoft has formed a flat base amid solid growth. Google is actionable now.

Via Investor's Business Daily

$1000 Invested In This Stock Over The Last 15 Years, Would Be Worth This Much ↗

November 17, 2021

West Pharmaceutical Servs (NYSE:WST) has outperformed the market over the past 15 years by 12.76% on an annualized basis. Buying $1,000 In WST: 15 years ago, an investor could...

Via Benzinga

Here's How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 15 Years ↗

November 09, 2021

West Pharmaceutical Servs (NYSE:WST) has outperformed the market over the past 15 years by 12.12% on an annualized basis. Buying $1,000 In WST: 15 years ago, an investor could...

Via Benzinga

When Winning Streaks Stop: Trying To Beat The Market By Buying Stocks Like Tesla ↗

November 08, 2021

Teslas getting charged in a Wawa parking lot last month. Photo via author. When Winning Streaks Stop In a post in August (Tesla And The Quest For Alpha), we wrote about how a...

Via Benzinga

Earnings Scheduled For October 28, 2021 ↗

October 28, 2021

Companies Reporting Before The Bell • LendingTree (NASDAQ:TREE) is estimated to report quarterly earnings at $0.57 per share on revenue of $292.63 million. •...

Via Benzinga

West Is Headed North ↗

August 25, 2021

Revenue is expected to grow 30.40% this year and another 8.00% next year. Earnings are estimated to increase 72.50% this year, an additional 7.20% next year.

Via Talk Markets

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline ↗

August 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business ↗

August 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc...

Via Benzinga

When Winning Streaks Stop ↗

November 07, 2021

Trying to beat the market by buying stocks like Tesla. It's probably impossible to time these things perfectly, but as we continue to collect data, we may be able to spend more time in winning...

Via Talk Markets

West Pharmaceutical Services (WST) Q3 2021 Earnings Call Transcript ↗

October 28, 2021

WST earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

West Pharmaceutical Services: Q3 Earnings Insights ↗

October 28, 2021

West Pharmaceutical Servs (NYSE:WST) reported its Q3 earnings results on Thursday, October 28, 2021 at 06:00 AM. Here's what investors need to know about the...

Via Benzinga

West Pharmaceutical Servs's Earnings: A Preview ↗

October 27, 2021

West Pharmaceutical Servs (NYSE:WST) is set to give its latest quarterly earnings report on Thursday, 2021-10-28. Here's what investors need to know before the announcement....

Via Benzinga

3 Healthcare Stocks to Buy and Hold for the Next 10 Years ↗

September 30, 2021

Consistency is the main attraction for these companies.

Via The Motley Fool

The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test ↗

September 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (...

Via Benzinga

Stocks That Hit 52-Week Highs On Thursday ↗

August 19, 2021

Before 10 a.m. ET on Thursday, 18 companies set new 52-week highs. Areas of Interest: Public Storage (NYSE:PSA) was the largest company by market cap to set a new...

Via Benzinga

The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization ↗

September 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...

Via Benzinga

Stocks That Hit 52-Week Highs On Wednesday ↗

August 18, 2021

Before 10 a.m. ET on Wednesday, 77 companies hit new 52-week highs. Areas of Significance: Pfizer (NYSE:PFE) was the largest firm on a market cap basis to set a new...

Via Benzinga

The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself ↗

September 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:...

Via Benzinga

Stocks That Hit 52-Week Highs On Wednesday ↗

August 04, 2021

Before 10 a.m. ET Wednesday, 138 stocks hit new 52-week highs. Key Facts: ASML Holding (NASDAQ:ASML) was the biggest company by market cap to set a new 52-week high...

Via Benzinga

The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering ↗

September 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU...

Via Benzinga

Stocks That Hit 52-Week Highs On Tuesday ↗

August 03, 2021

During Tuesday's morning trading, 101 companies set new 52-week highs. Intriguing Points: Nike (NYSE:NKE) was the biggest firm by market cap to hit a new 52-...

Via Benzinga

The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical ↗

August 31, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal ↗

August 24, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (...

Via Benzinga

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data ↗

August 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...

Via Benzinga

The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck ↗

August 19, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Stocks That Hit 52-Week Highs On Monday ↗

August 16, 2021

Before 10 a.m. ET on Monday, 71 companies hit new 52-week highs. Highlights: Apple (NASDAQ:AAPL) was the largest firm on a market cap basis to set a new 52-week...

Via Benzinga

The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering ↗

August 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,...

Via Benzinga

Stocks That Hit 52-Week Highs On Tuesday ↗

August 10, 2021

Before 10 a.m. ET on Tuesday, 100 stocks hit new 52-week highs. Things to Consider: The largest company by market cap to break to a new 52-week high was Pfizer (...

Via Benzinga

The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO ↗

August 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.